Sign In
12 Dec 2011 07:00
12 December 2011
Imaginatik plc
("Imaginatik" or the "Company")
Contract Win
Imaginatik plc (AIM: IMTK), a leading provider of enterprise innovation solutions including a range of technology products and consultancy, is pleased to announce it has signed a consultancy contract with a US based global leader in paediatric nutrition to enhance its innovation capabilities. No financial details have been disclosed.
This is a full service agreement whereby Imaginatik will assist the client in designing and implementing a complete, end-to-end innovation programme at the enterprise level. Imaginatik will support the client in developing an innovation process through the provision of its technology platform, Discovery Suite, in combination with innovation consultancy. In addition, Imaginatik will provide training to help the client build a core innovation team which will ensure a sustainable solution and repeatable process for innovation.
Matt Cooper, Executive Chairman of Imaginatik, commented, "This new contract is a strong endorsement of the evolution of the Imaginatik strategy towards providing end-to-end innovation programmes. We believe Imaginatik now occupies a unique position in its market as the only company with the proven ability to support sustainable enterprise innovation programmes through a combination of technology, consultancy and repeatable processes."
For further information please contact:
Imaginatik plc | Tel: 020 7917 2975 |
Matt Cooper, Executive Chairman / Shawn Taylor, CFO | |
Northland Capital Partners Limited | Tel: 020 7796 8800 |
Gavin Burnell / Edward Hutton | |
Threadneedle Communications | Tel: 020 7653 9850 |
Caroline Evans-Jones / Hilary Millar |
About Imaginatik
Imaginatik provides Innovation and Idea management solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.
Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.
Follow the stocks
